Literature DB >> 2422462

Perfused rabbit heart: endothelium-derived relaxing factor in coronary arteries.

M Saeed, J Schmidli, M Metz, R J Bing.   

Abstract

The study was performed to demonstrate the presence of the endothelium-derived relaxing factor (EDRF), previously found to be active in isolated artery preparations in vitro, in the coronary arteries of rabbits remaining in contact with the beating perfused heart. This was accomplished by following the response of the preconstricted obtuse marginal coronary artery to topically administered acetylcholine (ACH). Both intact arteries and arteries in which the endothelium had been removed were studied. Preconstriction of the obtuse marginal coronary artery was accomplished by topical application (spray) of histamine (10 microM), in 2 ml Krebs-Henseleit (KH) solution. This resulted in a decrease in internal diameter of the coronary artery, a decline in coronary flow, and an increase in total coronary vascular resistance. The principal difference between intact coronary arteries and those in which the endothelium had been removed was in the response to ACH. In arteries with intact endothelium preconstricted with histamine, topical administration (spray) of ACH (0.6 mM in 2 ml KH solution) caused, as compared with histamine, an increase in coronary flow, a significant decrease in total coronary vascular resistance, and a rise in internal vascular diameter. Arteries in which the vascular endothelium had been removed, as compared to those pretreated with histamine, responded to topical administration of ACH (0.6 mM in 2 ml KH solution) with a decrease in coronary flow, coronary vascular resistance, and internal vascular diameter. No change in the dose-response curve to histamine between the two preparations was noted. The results demonstrate that coronary vascular endothelium exerts a protective effect in coronary arteries remaining in contact with the perfused beating heart.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422462     DOI: 10.1097/00005344-198603000-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  On-line measurement of nitric oxide release from organic nitrates in the intact coronary circulation.

Authors:  K Schrör; S Förster; I Woditsch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

2.  Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia.

Authors:  P Milner; V Ralevic; A M Hopwood; E Fehér; J Lincoln; K A Kirkpatrick; G Burnstock
Journal:  Experientia       Date:  1989-02-15

3.  Removal of endothelial function in coronary resistance vessels by saponin.

Authors:  E Wiest; V Trach; J Dämmgen
Journal:  Basic Res Cardiol       Date:  1989 Sep-Oct       Impact factor: 17.165

4.  A relaxing factor released by phospholipase A2 in the absence of endothelium.

Authors:  R J Bing; M Saeed
Journal:  Mol Cell Biochem       Date:  1987-11       Impact factor: 3.396

5.  Effects of nitric oxide synthase inhibitors, L-NG-nitroarginine and L-NG-nitroarginine methyl ester, on responses to vasodilators of the guinea-pig coronary vasculature.

Authors:  A Vials; G Burnstock
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.